BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38554847)

  • 1. Prominent role of gut dysbiosis in the pathogenesis of cystic fibrosis-related liver disease in mice.
    Bertolini A; Nguyen M; Zehra SA; Taleb SA; Bauer-Pisani T; Palm N; Strazzabosco M; Fiorotto R
    J Hepatol; 2024 Mar; ():. PubMed ID: 38554847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fecal dysbiosis and inflammation in intestinal-specific Cftr knockout mice on regimens preventing intestinal obstruction.
    Young SM; Woode RA; Williams EC; Ericsson AC; Clarke LL
    Physiol Genomics; 2024 Mar; 56(3):247-264. PubMed ID: 38073491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice.
    Fiorotto R; Scirpo R; Trauner M; Fabris L; Hoque R; Spirli C; Strazzabosco M
    Gastroenterology; 2011 Oct; 141(4):1498-508, 1508.e1-5. PubMed ID: 21712022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet-Induced Dysbiosis and Genetic Background Synergize With Cystic Fibrosis Transmembrane Conductance Regulator Deficiency to Promote Cholangiopathy in Mice.
    Debray D; El Mourabit H; Merabtene F; Brot L; Ulveling D; Chrétien Y; Rainteau D; Moszer I; Wendum D; Sokol H; Housset C
    Hepatol Commun; 2018 Dec; 2(12):1533-1549. PubMed ID: 30556040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fecal Dysbiosis and Inflammation in Intestinal-Specific Cftr Knockout Mice on Regimens Preventing Intestinal Obstruction.
    Young SM; Woode RA; Williams E; Ericsson A; Clarke LL
    bioRxiv; 2023 Jul; ():. PubMed ID: 37546931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal
    Price CE; Valls RA; Ramsey AR; Loeven NA; Jones JT; Barrack KE; Schwartzman JD; Royce DB; Cramer RA; Madan JC; Ross BD; Bliska J; O'Toole GA
    mBio; 2024 Feb; 15(2):e0314423. PubMed ID: 38179971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathophysiology of Cystic Fibrosis Liver Disease: A Channelopathy Leading to Alterations in Innate Immunity and in Microbiota.
    Fiorotto R; Strazzabosco M
    Cell Mol Gastroenterol Hepatol; 2019; 8(2):197-207. PubMed ID: 31075352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular chloride and bicarbonate retention alters intracellular pH regulation in Cftr KO crypt epithelium.
    Walker NM; Liu J; Stein SR; Stefanski CD; Strubberg AM; Clarke LL
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(2):G70-80. PubMed ID: 26542396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations of mucosa-attached microbiome and epithelial cell numbers in the cystic fibrosis small intestine with implications for intestinal disease.
    Kelly J; Al-Rammahi M; Daly K; Flanagan PK; Urs A; Cohen MC; di Stefano G; Bijvelds MJC; Sheppard DN; de Jonge HR; Seidler UE; Shirazi-Beechey SP
    Sci Rep; 2022 Apr; 12(1):6593. PubMed ID: 35449374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystic Fibrosis-Related Gut Dysbiosis: A Systematic Review.
    Caley LR; White H; de Goffau MC; Floto RA; Parkhill J; Marsland B; Peckham DG
    Dig Dis Sci; 2023 May; 68(5):1797-1814. PubMed ID: 36600119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity.
    Fiorotto R; Villani A; Kourtidis A; Scirpo R; Amenduni M; Geibel PJ; Cadamuro M; Spirli C; Anastasiadis PZ; Strazzabosco M
    Hepatology; 2016 Dec; 64(6):2118-2134. PubMed ID: 27629435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung and Gut Microbiota Changes Associated with
    Bacci G; Rossi A; Armanini F; Cangioli L; De Fino I; Segata N; Mengoni A; Bragonzi A; Bevivino A
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis.
    Spatz M; Ciocan D; Merlen G; Rainteau D; Humbert L; Gomes-Rochette N; Hugot C; Trainel N; Mercier-Nomé F; Domenichini S; Puchois V; Wrzosek L; Ferrere G; Tordjmann T; Perlemuter G; Cassard AM
    JHEP Rep; 2021 Apr; 3(2):100230. PubMed ID: 33665587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goblet cell hyperplasia is not epithelial-autonomous in the Cftr knockout intestine.
    Walker NM; Liu J; Young SM; Woode RA; Clarke LL
    Am J Physiol Gastrointest Liver Physiol; 2022 Feb; 322(2):G282-G293. PubMed ID: 34878935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cystic Fibrosis Liver Disease: Know More.
    Al Sinani S; Al-Mulaabed S; Al Naamani K; Sultan R
    Oman Med J; 2019 Nov; 34(6):482-489. PubMed ID: 31745411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis rabbits develop spontaneous hepatobiliary lesions and CF-associated liver disease (CFLD)-like phenotypes.
    Wu Q; Liang X; Hou X; Song Z; Bouhamdan M; Qiu Y; Koike Y; Rajagopalan C; Wei HG; Jiang H; Hish G; Zhang J; Chen YE; Jin JP; Xu J; Zhang K; Sun F
    PNAS Nexus; 2023 Jan; 2(1):pgac306. PubMed ID: 36712930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Src kinase inhibition reduces inflammatory and cytoskeletal changes in ΔF508 human cholangiocytes and improves cystic fibrosis transmembrane conductance regulator correctors efficacy.
    Fiorotto R; Amenduni M; Mariotti V; Fabris L; Spirli C; Strazzabosco M
    Hepatology; 2018 Mar; 67(3):972-988. PubMed ID: 28836688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Catenin-NF-κB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction.
    Hu S; Russell JO; Liu S; Cao C; McGaughey J; Rai R; Kosar K; Tao J; Hurley E; Poddar M; Singh S; Bell A; Shin D; Raeman R; Singhi AD; Nejak-Bowen K; Ko S; Monga SP
    Elife; 2021 Oct; 10():. PubMed ID: 34609282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron Homeostasis and Inflammatory Status in Mice Deficient for the Cystic Fibrosis Transmembrane Regulator.
    Deschemin JC; Allouche S; Brouillard F; Vaulont S
    PLoS One; 2015; 10(12):e0145685. PubMed ID: 26709821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium.
    Scirpo R; Fiorotto R; Villani A; Amenduni M; Spirli C; Strazzabosco M
    Hepatology; 2015 Nov; 62(5):1551-62. PubMed ID: 26199136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.